Director's Dealing • Mar 14, 2022
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 7387E
Burberry Group PLC
14 March 2022
Burberry Group plc (the "Company") - Director/PDMR Shareholding
The Company announces that it received notification on Monday, 14 March 2022 that Dr Gerry Murphy, Chair and a Director of the Company, purchased 5,000 Ordinary Shares of 0.05 pence each in the Company ("Shares") on 14 March 2022 at a price of 1612.7094 pence per Share.
14 March 2022
The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.
Notification of dealing form
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Dr Gerard Martin Murphy
2
Reason for the notification
a)
Position/status
Chair and a Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Burberry Group plc
b)
LEI
213800PE1KEFCNFR1R50
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.05 pence each
GB0031743007
b)
Nature of the transaction
Purchase of ordinary shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £16.127094 | 5,000 |
d)
Aggregated information
- Aggregated volume
- Price
| Aggregate Price | Aggregate Volume | Aggregate Total |
| £16.127 | 5,000 | £80,635.47 |
e)
Date of the transaction
2022-03-14
f)
Place of the transaction
XLON and outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFVDVIISLIF
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.